US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)

0.0058

0.0000

Volume:- -

Turnover:- -

Market Cap:57.29K

PE:0.02

High:0.0058

Open:0.0058

Low:0.0058

Close:0.0058

52wk High:0.0058

52wk Low:0.0058

Shares:9.88M

Float Shares:- -

Volume Ratio:4.57

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3636

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)

Exchange:

NYSE

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.calidibio.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate and deliver oncolytic viruses to cancer patients in the United States. Its product pipeline comprising CLD-101, which is in phase 1b clinical trial for the treatment of high grade glioma; CLD-101, which is in phase 1 clinical trial for the treatment of recurrent high grade glioma; CLD-201, which is in preclinical trial for the treatment of advanced solid tumors, such as triple-negative breast cancer, metastatic/unresectable melanoma, head and neck squamous cell carcinoma, advanced soft tissue sarcoma, and advanced basal cell carcinoma; and CLD-400, which is in preclinical trial for the treatment of lung cancer and metastatic solid tumors. The company offers NeuroNova platform and SuperNova platform. The company is headquartered in San Diego, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CLDI.WS/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CLDI.WS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLDI.WS\",,,,,undefined,":{"symbol":"CLDI.WS","market":"US","secType":"STK","nameCN":"CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)","latestPrice":0.0058,"timestamp":1770757200000,"preClose":0.0058,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":0,"shares":9878020,"eps":0.36356,"marketStatus":"Halted","change":0,"latestTime":"02-11 05:09:03 EST","open":0.0058,"high":0.0058,"low":0.0058,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.36356,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770820200000},"marketStatusCode":1,"adr":0,"exchange":"NYSE","adjPreClose":0.0058,"volumeRatio":4.567179151938678},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CLDI.WS\",,,,,undefined,":{"symbol":"CLDI.WS","floatShares":0,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.567179151938678,"shares":9878020,"dividePrice":0,"high":0.0058,"amplitude":0,"preClose":0.0058,"low":0.0058,"week52Low":0.0058,"pbRate":"--","week52High":0.0058,"institutionHeld":0,"latestPrice":0.0058,"eps":0.36356,"divideRate":0,"volume":0,"delay":0,"ttmEps":0.36356,"open":0.0058,"prevYearClose":0.0058,"prevWeekClose":0.0058,"prevMonthClose":0.0058,"prevQuarterClose":0.0058,"fiveDayClose":0.0058,"twentyDayClose":0.0058,"sixtyDayClose":0.0058},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CLDI.WS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CLDI.WS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CLDI.WS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.calidibio.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0038},{"period":"1month","weight":-0.0028},{"period":"3month","weight":0.0128},{"period":"6month","weight":0.0731},{"period":"1year","weight":0.1443},{"period":"ytd","weight":0.015}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing allogeneic stem cell-based platforms to potentiate and deliver oncolytic viruses to cancer patients in the United States. Its product pipeline comprising CLD-101, which is in phase 1b clinical trial for the treatment of high grade glioma; CLD-101, which is in phase 1 clinical trial for the treatment of recurrent high grade glioma; CLD-201, which is in preclinical trial for the treatment of advanced solid tumors, such as triple-negative breast cancer, metastatic/unresectable melanoma, head and neck squamous cell carcinoma, advanced soft tissue sarcoma, and advanced basal cell carcinoma; and CLD-400, which is in preclinical trial for the treatment of lung cancer and metastatic solid tumors. The company offers NeuroNova platform and SuperNova platform. The company is headquartered in San Diego, California.","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.141864},{"month":2,"riseRate":0.5,"avgChangeRate":0.375366},{"month":3,"riseRate":0,"avgChangeRate":-0.288504},{"month":4,"riseRate":0.666667,"avgChangeRate":0.298619},{"month":5,"riseRate":0,"avgChangeRate":-0.076923},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.085582},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.132847},{"month":8,"riseRate":0.333333,"avgChangeRate":0.085174},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.196177},{"month":10,"riseRate":0,"avgChangeRate":-0.457774},{"month":11,"riseRate":0.5,"avgChangeRate":-0.207855},{"month":12,"riseRate":0.666667,"avgChangeRate":0.701396}],"exchange":"NYSE","name":"CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)","nameEN":"CALIDI BIOTHERAPEUTICS INC C/WTS 14/03/2028 (TO PUR COM)"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CLDI.WS\",market:\"US\",,,undefined,":null}}